Clinical Trial Update: Tirzepatide Weight Loss for MRD+ Early Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating tirzepatide for weight loss in patients with MRD-positive early breast cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Baylor Research Institute | Conditions: Breast Cancer, Breast Neoplasms | Phase 2 | Status: RECRUITING